Cargando…
Identification of predictors of drug sensitivity using patient-derived models of esophageal squamous cell carcinoma
Previous studies from the Cancer Cell Line Encyclopedia (CCLE) project have adopted commercial pan-cancer cell line models to identify drug sensitivity biomarkers. However, drug sensitivity biomarkers in esophageal squamous cell carcinoma (ESCC) have not been widely explored. Here, eight patient-der...
Autores principales: | Su, Dan, Zhang, Dadong, Jin, Jiaoyue, Ying, Lisha, Han, Miao, Chen, Kaiyan, Li, Bin, Wu, Junzhou, Xie, Zhenghua, Zhang, Fanrong, Lin, Yihui, Cheng, Guoping, Li, Jing-Yu, Huang, Minran, Wang, Jinchao, Wang, Kailai, Zhang, Jianjun, Li, Fugen, Xiong, Lei, Futreal, Andrew, Mao, Weimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838071/ https://www.ncbi.nlm.nih.gov/pubmed/31700061 http://dx.doi.org/10.1038/s41467-019-12846-7 |
Ejemplares similares
-
Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma
por: Chen, Kaiyan, et al.
Publicado: (2016) -
Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma
por: Chen, Kaiyan, et al.
Publicado: (2017) -
Overcoming Linsitinib intrinsic resistance through inhibition of nuclear factor‐κB signaling in esophageal squamous cell carcinoma
por: Wu, Junzhou, et al.
Publicado: (2017) -
Non-disruptive mutation in TP53 DNA-binding domain is a beneficial factor of esophageal squamous cell carcinoma
por: Huang, Minran, et al.
Publicado: (2020) -
High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods
por: Su, Dan, et al.
Publicado: (2017)